评估葡萄糖对女性缺铁性贫血的影响:一项随机临床试验
Rasul Pourhakim1, Fatemeh Emadi1,2, Saeed Razavi Dizaji3
1Department of Traditional Medicine, School of Persian Medicine Shahed University Tehran Iran.
Food science & nutrition
|August 14, 2024
概括
葡萄糖可以增强女性缺铁性贫血的治疗. 将葡萄糖与铁补充剂相结合,比单独的铁更能改善血红蛋白和血红素水平.
科学领域:
- 营养科学 营养科学
- 血液学 血液学 血液学
- 公共卫生 公共卫生
背景情况:
- 缺铁性贫血是一种广泛的营养障碍,特别影响生育年龄的妇女.
- 目前的铁补充剂是有效的,但可能会导致不良副作用.
- 葡萄糖 (GS) 是一种功能性富含铁的食物,正在作为一种补充治疗方法进行探索.
研究的目的:
- 研究葡萄糖在调节女性缺铁性贫血标志物的有效性.
- 为了比较葡萄糖与铁片相结合的效果与单独的铁片.
主要方法:
- 一项为期4周的随机,双盲,安慰剂对照研究,涉及130名女性.
- 干预组接受了硫酸铁加葡萄糖;安慰剂组接受了硫酸铁加安慰剂糖.
- 评估的标记物包括血红蛋白,血红素,红细胞计数,平均体积,费里丁,总铁结合能力和血清铁.
主要成果:
- 在葡萄糖组 (p < .05) 观察到血红蛋白和血红素的显著增加.
- 与安慰剂相比,红细胞计数和平均体积也显著改善 (p < .05).
- 两组之间血清铁,费里丁或铁的总结合能力没有显著差异 (p > .05).
结论:
- 将葡萄糖与铁片结合使用可能对女性治疗缺铁性贫血有好处.
- 葡萄糖显示出作为辅助疗法的潜力,以改善关键的血液学标记.
- 进一步的研究是有必要的,以探索机制和长期影响.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
388
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
388
Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252
Dosage Regimens: Designs and Approaches
605
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
605


